Skin Cleansing and Disinfection

Description

The Framework Agreement is for the supply of skin cleansing and disinfection products for patient use, including but not limited to patient cleansing wipes, patient cleansing and hygiene products, localised alcohol skin cleansing and decolonisation wipes, body cleansing and decolonisation products, biocides, and skin disinfection medicinal products. The Framework Agreement will have an initial term of 36 months with an option to extend incrementally for up to a total period of 48 months. It is anticipated that in the first 36 months of the Framework Agreement the value of purchases will be in the region of £70,600,000 GBP ex VAT. For the full 48 month term (if extended) the anticipated value is £94,750,000 GBP ex VAT. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business. Lot 1A: Patient Cleansing Wipes - Non Maceratable This Lot is for wipes used for the personal hygiene and cleansing of patients of all ages including (but not limited to) hand, face, body and bed bath wipes. There are two sub-categories under this Lot: 1) Sub-category A – Non-maceratable Wipes This sub-category is for non-maceratable patient cleansing wipes, that are not disposed of in a macerator after use. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for Lot 1A and 1B combined will be circa £3,998,315 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £5,364,544 GBP ex VAT. Lot 1B: Patient Cleansing Wipes - Maceratable This Lot is for wipes used for the personal hygiene and cleansing of patients of all ages including (but not limited to) hand, face, body and bed bath wipes. There are two sub-categories under this Lot. This Sub Category is: 2) Sub-category B – Maceratable Wipes This sub-category is for patient cleansing wipes that are disposed of in a macerator after use. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for Lot 1A and Lot 1B combined will be circa £3,998,315 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £5,364,544 GBP ex VAT. Lot 2: Continence Wipes This Lot is for continence wipes only used for patient personal hygiene. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £5,536,129 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £7,427,830 GBP ex VAT Lot 3: Patient Cleansing and Hygiene Products This Lot is for non-wipe products used for patient cleansing and hygiene including (but not limited to) shampoo, shower gel, shampoo caps without medicinal properties, tablet soap, body wash, and baby bath. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £2,183,695 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £2,929,866 GBP ex VAT. Lot 4: Localised Alcohol Skin Cleansing and Decolonisation Wipes This Lot is for products used for localised cleaning and decolonisation of skin including (but not limited to) alcohol wipes with chlorhexidine and alcohol swabs. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £2,980,283 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £3,998,649 GBP ex VAT. Lot 5: Body Cleansing and Decolonisation This Lot is for antimicrobial products used for the cleaning of patients’ hair and body, including products used for the decolonisation of patients’ skin and mucosa prior to procedure, including (but not limited to) wipes, shampoo caps, body wash, mouth wash, sponges, nasal gel and disinfectant solutions for general skin cleansing and decolonisation. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £6,581,842 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £8,830,865 GBP ex VAT. Lot 6: Skin Disinfection (Medicinal Products) This Lot is for medicinal products and associated products only, used for the cleansing, disinfection and decolonisation of a clinician’s and/or a patient’s skin including (but not limited to) surgical scrub solutions, surgical skin preparation products, mouth wash, and related dispensers. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £48,594,906 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £65,199,842 GBP ex VAT. Lot 7: Nursing Sundries This Lot is for skin cleansing and care nursing sundries not listed in Lots 1 to 6. Products include (but are not limited to) nursing sundries, emollients, creams and liquids used in patient care such as protection creams, zinc and castor oil ointment, yellow soft paraffin, and nail varnish remover. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £722,772 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £969,744 GBP ex VAT. Lot 1A: Patient Cleansing Wipes - Non Maceratable This Lot is for wipes used for the personal hygiene and cleansing of patients of all ages including (but not limited to) hand, face, body and bed bath wipes. There are two sub-categories under this Lot: 1) Sub-category A – Non-maceratable Wipes This sub-category is for non-maceratable patient cleansing wipes, that are not disposed of in a macerator after use. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for Lot 1A and 1B combined will be circa £3,998,315 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £5,364,544 GBP ex VAT. Lot 1B: Patient Cleansing Wipes - Maceratable This Lot is for wipes used for the personal hygiene and cleansing of patients of all ages including (but not limited to) hand, face, body and bed bath wipes. There are two sub-categories under this Lot. This Sub Category is: 2) Sub-category B – Maceratable Wipes This sub-category is for patient cleansing wipes that are disposed of in a macerator after use. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for Lot 1A and Lot 1B combined will be circa £3,998,315 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £5,364,544 GBP ex VAT. Lot 2: Continence Wipes This Lot is for continence wipes only used for patient personal hygiene. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £5,536,129 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £7,427,830 GBP ex VAT Lot 3: Patient Cleansing and Hygiene Products This Lot is for non-wipe products used for patient cleansing and hygiene including (but not limited to) shampoo, shower gel, shampoo caps without medicinal properties, tablet soap, body wash, and baby bath. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £2,183,695 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £2,929,866 GBP ex VAT. Lot 4: Localised Alcohol Skin Cleansing and Decolonisation Wipes This Lot is for products used for localised cleaning and decolonisation of skin including (but not limited to) alcohol wipes with chlorhexidine and alcohol swabs. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £2,980,283 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £3,998,649 GBP ex VAT. Lot 5: Body Cleansing and Decolonisation This Lot is for antimicrobial products used for the cleaning of patients’ hair and body, including products used for the decolonisation of patients’ skin and mucosa prior to procedure, including (but not limited to) wipes, shampoo caps, body wash, mouth wash, sponges, nasal gel and disinfectant solutions for general skin cleansing and decolonisation. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £6,581,842 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £8,830,865 GBP ex VAT. Lot 6: Skin Disinfection (Medicinal Products) This Lot is for medicinal products and associated products only, used for the cleansing, disinfection and decolonisation of a clinician’s and/or a patient’s skin including (but not limited to) surgical scrub solutions, surgical skin preparation products, mouth wash, and related dispensers. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £48,594,906 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £65,199,842 GBP ex VAT. Lot 7: Nursing Sundries This Lot is for skin cleansing and care nursing sundries not listed in Lots 1 to 6. Products include (but are not limited to) nursing sundries, emollients, creams and liquids used in patient care such as protection creams, zinc and castor oil ointment, yellow soft paraffin, and nail varnish remover. Additional information: It is anticipated that in the first 36 months of the Framework Agreement the value of purchases for this Lot will be circa £722,772 GBP ex VAT and for the full 48 month term (if extended) the anticipated value will be circa £969,744 GBP ex VAT.